Skip Navigation

Cardiovascular Research 2003 57(1):217-224; doi:10.1016/S0008-6363(02)00648-X
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mutafova-Yambolieva, V. N.
Right arrow Articles by Bobalova, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mutafova-Yambolieva, V. N.
Right arrow Articles by Bobalova, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Involvement of cyclic AMP-mediated pathway in neural release of noradrenaline in canine isolated mesenteric artery and vein

Violeta N. Mutafova-Yambolieva*, Lisa Smyth and Janette Bobalova

Department of Physiology and Cell Biology, Anderson Medical Building/MS 352, University of Nevada School of Medicine, Reno, NV 89557-0046, USA

* Corresponding author. Tel.: +1-775-784-4302; fax: +1-775-784-6903. vnm{at}med.unr.edu

Objective: Our major hypothesis is that cyclic adenosine-3',5'-monophosphate (cAMP)-mediated modulation of neurotransmitter release plays different roles at low and high activity of the sympathetic nervous system. We further hypothesize that cAMP-mediated neuromodulation might underlie disparate neurovascular control in mesenteric arteries and veins. Methods: Electrical field stimulation (EFS)-evoked overflow of noradrenaline (NA) was evaluated in the absence or presence of activators and inhibitors of cAMP-dependent pathway at low (4 Hz) and high (16 Hz) frequencies of stimulation of endothelium-denuded secondary and tertiary branches of the canine isolated inferior mesenteric arteries and veins. The content of NA in samples of the superfusates collected before and during nerve stimulation was assayed by high-performance liquid chromatography (HPLC) technique in conjunction with electrochemical detection. Student's t-test and ANOVA analyses were applied for statistical analysis. Results: Activation of cAMP-dependent pathway with either isoproterenol (ISO, 10 µM), forskolin (1 µM), dibutyryl cAMP (100 µM) or combined site-specific activators of cAMP-dependent protein kinase (PKA) [i.e. N6-phenyl-adenosine-3',5'-cyclic monophosphate, 8-(6-aminohexyl) aminoadenosine-3',5'-cyclic monophosphate, and the Sp-isomer of 5,6-dichloro-1-D-ribofuranosylbenzimidazole-3',5'-cyclic monophosphorothioate, each 100 µM] caused an enhancement of the EFS-evoked overflow of endogenous NA at 16 Hz of stimulation but was without an effect at 4 Hz of stimulation both in artery and vein. The EFS (16 Hz)-evoked overflow of NA in vein was also increased in the presence of inhibitors of phosphodiesterase (PDE) III and PDE IV (i.e. milrinone, 0.4 µM, and roilpram, 30 µM), whereas these inhibitors did not affect the overflow of NA in the artery. The facilitating effect of activators of cAMP-dependent pathway on the EFS-evoked release of NA at 16 Hz appears to be more pronounced in the vein than in artery. The increasing effect of ISO (10 µM) was inhibited with either propranolol (1 µM) or the adenylyl cyclase (AC) inhibitor [9-(tetrahydro-2'-furyl)adenine] (SQ 22,536, 100 µM) in both blood vessels. The ISO effect was inhibited by the PKA inhibitor 14–22 amide (PKI14–22), 1 µM, in the artery but not in vein. The enhancing effect of FSK was inhibited by pretreatment of the tissue with SQ 22,536, 100 µM, or the PKA inhibitors PKI14–22, 1 µM, and 4-cyano-3-methylisoquinoline, 50 nM. However, the inhibitors alone did not significantly change the EFS-evoked overflow of NA in both blood vessels. Conclusions: Activation of AC–cAMP–PKA pathway appears to play a role in modulating NA release at higher stimulation frequencies as might be expected during stress, strenuous exercise, or hemorrhage. The AC–cAMP pathway plays a more pronounced role in the autonomic neural control of mesenteric veins than of the corresponding arteries, whereas the PKA contribution is more distinct in the arteries.

KEYWORDS Arteries; Autonomic nervous system; Neurotransmitters; Second messengers; Veins


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. M. Smyth, L. T. Breen, and V. N. Mutafova-Yambolieva
Nicotinamide adenine dinucleotide is released from sympathetic nerve terminals via a botulinum neurotoxin A-mediated mechanism in canine mesenteric artery
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1818 - H1825.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Smyth, J. Bobalova, M. G. Mendoza, C. Lew, and V. N. Mutafova-Yambolieva
Release of {beta}-Nicotinamide Adenine Dinucleotide upon Stimulation of Postganglionic Nerve Terminals in Blood Vessels and Urinary Bladder
J. Biol. Chem., November 19, 2004; 279(47): 48893 - 48903.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Fresco, C. Diniz, and J. Goncalves
Facilitation of noradrenaline release by activation of adenosine A2A receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery
Cardiovasc Res, September 1, 2004; 63(4): 739 - 746.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.